focus -WSS

focus

author：Wikipedia 2025-10-01 11:46:04 - browse：2

Vir Biotechnology said Thursday that a long-acting antibody drug designed to protect healthy individuals from influenza A failed to do so in a nearly 3,000-person clinical trial.

Volunteers who received the highest dose of the drug, known as VIR-2482, were only 16% less likely than the placebo group to develop symptomatic influenza A infections, as defined by trial criteria, over a seven-month period. The difference was not statistically significant.

The results are a setback in broader efforts to develop better protective measures against both seasonal and potential pandemic influenza strains. In the short term, Vir and outside experts hoped VIR-2482 could provide additional annual protection for at-risk groups like older adults, as flu vaccines are often only modestly effective.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Superbugs, antibiotic resistance get scrutiny in congress

hotspot

WSS

Covid hospitalizations on the rise, Humana says

Companies helping big Covid

Seth Rogen and Lauren Miller Rogen on Alzheimer's caregiving

Rapinoe says her retirement call will help US women's soccer team to focus at World Cup

How generative AI is inspiring dreams of a health data revolution

Russia's threat to pull out of Ukraine grain deal raises fears about global food security

Wikipedia

focus

knowledge

Apple is now the first public company to be valued at $3 trillion

How to fix cancer clinical trials' diversity problem

Dobbs anniversary: the lost opportunity of abortion as health care

Illumina names Agilent executive as new CEO

23andMe had bad news about my health. I wish a person had delivered it

Women's World Cup brings attention to abuse in soccer

DIEP, the 'gold standard' of breast reconstruction, is under threat

'Make People Better': The CRISPR babies story you probably don't know

Malaria cases in Florida and Texas: Here’s what you need to know

How to protect patients from sexual assault

entertainment

China sends large group of warplanes, navy ships towards Taiwan in forceful display

Russia's threat to pull out of Ukraine grain deal raises fears about global food security

Ethical issues complicate the benefits of medical crowdfunding

How are insurers handling Leqembi and related scans?

Illumina names Agilent executive as new CEO

How generative AI is inspiring dreams of a health data revolution

Wikipedia

entertainment

hotspot

leisure time